Precision System Science Co (7707.T) Stock Price

Precision System Science Co Price

CLOSED
182.00
​
Market closed

Revenue has compounded at 1.8% per year over the past 19 years to 5.22 B JPY. Earnings per share have grown at 7.4% per year over the last 17 years. Precision System Science Co's net margin stands at 7.6%, up from 0.6% several years earlier. Precision System Science Co currently offers a dividend yield of about 2.75%. The payout ratio is around 18% of earnings.

Precision System Science Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Precision System Science Co business model & stock analysis

Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments.

Frequently asked questions about Precision System Science Co

The business model of Precision System Science Co Ltd is focused on providing innovative solutions in the field of life science research and diagnostics. The company specializes in developing and manufacturing advanced instruments, equipment, and consumables for genetic testing, nucleic acid purification, and molecular biology applications. Precision System Science Co Ltd aims to contribute to scientific advancements and improve healthcare outcomes through its cutting-edge technologies and products. The company's commitment to continuous innovation and high-quality solutions has made it a leading player in the industry.

Precision System Science Co Ltd is primarily active in the life sciences and healthcare industries.

The main competitors of Precision System Science Co Ltd in the market are companies like Thermo Fisher Scientific Inc., Beckman Coulter, Inc., and Roche Diagnostics.

Precision System Science Co Ltd (PSS) is a renowned company in the field of life sciences and biotechnology. Established in 1986, PSS has since been dedicated to developing innovative solutions and high-quality products for the life sciences industry. With its headquarters in Japan, PSS has expanded globally, with subsidiaries and distributors across various countries. The company focuses on providing advanced technologies, including PCR instruments, nucleic acid extraction systems, automated liquid handling systems, and more. PSS's commitment to research and development has led to breakthroughs in molecular biology, diagnostics, and genomics. Today, Precision System Science Co Ltd continues to be a leading force driving advancements in the life sciences sector.

Precision System Science Co Ltd has achieved several significant milestones. It has successfully established itself as a key player in the life science industry, offering innovative solutions and products. The company has made remarkable progress in the field of genomic research and development, contributing to advancements in precision medicine. Precision System Science Co Ltd has also achieved commendable success with its automated laboratory equipment, revolutionizing the efficiency and accuracy of scientific experiments. Furthermore, the company has expanded its global presence, forging strategic partnerships and collaborations with renowned institutions and multinational corporations. These accomplishments demonstrate Precision System Science Co Ltd's commitment to technological excellence and its position as a leader in the industry.

Precision System Science Co Ltd is primarily present in Japan.

Precision System Science Co Ltd (PSS) is a leading company in the field of life sciences and diagnostics. Their values revolve around innovation, quality, and customer satisfaction. PSS is committed to providing reliable and cutting-edge solutions that meet the evolving needs of the scientific community. With a corporate philosophy centered on integrity and transparency, PSS strives to contribute to society through advancements in healthcare and research. By continuously investing in research and development, PSS aims to deliver state-of-the-art technologies and services that empower their customers to achieve breakthroughs in their respective fields.

7 analysts currently rate the Precision System Science Co stock: 0 recommend buying, 3 holding and 4 selling.

Converted at the current exchange rate, the Precision System Science Co share trades at 1.03 EUR (182.00 JPY).

Precision System Science Co Ltd (PSS) is a Japanese company specializing in the development, manufacturing, and distribution of systems for molecular biology research and diagnostics. The company's business model includes several divisions, including consumables, instruments, services, and licensed products. In the consumables division, PSS offers a wide range of items needed for conducting molecular biology experiments. These include products such as PCR reagents, DNA extraction kits, probes and primers, electrophoresis kits, antibodies and proteins, cell culture media, and plate systems. PSS aims to provide highly effective technologies and reagents at every step of DNA analysis and manipulation to ensure precision and reproducibility of research results. In the instruments division, PSS offers automated systems that facilitate the work of laboratory personnel. Products include pipettors, thermocyclers, sample preparation stations, and cell manipulators. These instruments improve workflows and reduce human errors, resulting in higher efficiency and accuracy in experiment execution. PSS has gained recognition in the field of automated systems through the development of innovative high-throughput systems and analytical platforms. PSS also offers a variety of services, including customer support, training, repairs, and validation services. Through its extensive services, PSS ensures that customer performance is enhanced through highly efficient and reliable processes. Licensing of technologies and products is also an important component of PSS's business model. The company collaborates closely with companies and institutions to commercialize their technologies and distribute their products globally. PSS focuses on the development of products and technologies that align with the needs and advancements in molecular biology research and diagnostics. The company has established itself as a pioneer in the field of DNA manipulation and analysis, underscored by a strong research and development department. PSS's products are used by scientists and researchers worldwide to make groundbreaking discoveries and advance knowledge in biological science. Overall, PSS aims to strengthen and expand its market position by creating an increasingly diverse product range and a stronger presence in the global market. The company is committed to understanding and meeting customer needs in order to develop ever more innovative products and technologies. PSS is a company focused on promoting scientific knowledge and advancements worldwide while always keeping its environmental and societal responsibilities in mind.

The revenue of Precision System Science Co is 5.22 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of Precision System Science Co is 394.87 M JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Precision System Science Co is currently 12.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Precision System Science Co stock.

The price-to-sales ratio (P/S) of Precision System Science Co is currently 0.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Precision System Science Co stock.

The Eulerpool Quality Score for Precision System Science Co is 3/10.

The ISIN of Precision System Science Co is JP3833400009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Precision System Science Co is 7707.T. The ticker symbol is used to trade Precision System Science Co shares on the stock exchange.

Fair ValueTerminal
191.10 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
31.43 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website pss.co.jp
Country
Currency
JPY
Initial public offering
Feb 1, 2001
ISIN
JP3833400009
Cusip
J6397V109
Sedol
6318246
Market capitalization
5.00 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
—
P/S
P/Se
—
EV/EBIT
23.16
P/B Ratio
1.22
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.72 %
Last updated Nov 9, 2026, 1:56 PM

Precision System Science Co FIGI

7707:JP · BBG000F6HFK57707:JT · BBG000F6HG327707:JJ · BBG000F6HNF47707:JE · BBG000F6HQP67707:JI · BBG000F6HR29PCNEF:US · BBG000GPV458PCNEF:PQ · BBG002J8Z197PCNEF:UV · BBG002J8Z1C37707:JU · BBG002QKC0H07707:JW · BBG00875H3C57707:JV · BBG0193R9BF6